Webinar | June 2, 2017

Evidence-Based Approaches For Accelerating Patient Enrollment In Oncology

Source: Covance

The number of oncology clinical trials has increased exponentially in recent years, putting ever more pressure on increasing clinical trial efficiency by reducing costs and timelines. Patient recruitment swallows 40% of trial costs, yet only 10–17% of studies enroll on time and approximately 11% of sites in any given study fail to enroll a single patient.

The excessive amount of time taken for patient recruitment, which can reach 60% of the total trial time, can be drastically reduced by identifying experienced investigators, ensuring access to specific patient pools and seeking sufficient infrastructure for optimal trial execution.

Join our webinar as we highlight proven solutions for overcoming the enormous challenge of study planning and patient recruitment. Also, learn more about how the Covance informatics platform solves patient recruitment challenges by using strategic, evidence-based methodologies. Xcellerate® Trial Design is the most extensive knowledgebase in the industry, making powerful use of a combination of LabCorp and Covance data on over 13 billion lab tests, 142 million de-identified patients from over 750K heathcare providers in Labcorp; 175,000 unique investigators and over 15,000 protocols in CLS. These approaches are proven to accelerate patient enrollment, reduce the proportion of non-recruiting sites leading to shorter timelines and reduced costs.